ANI Pharmaceuticals is a diversified drugmaker headquartered in Princeton, New Jersey, operating across three segments: rare disease, generics and established brands. Its flagship product is Cortrophin Gel (repository corticotropin injection), a purified adrenocorticotropic hormone therapy used in conditions spanning rheumatology, neurology and ophthalmology. On …
Efforts to confirm a listed operating company behind the AVOA ticker were inconclusive. Standard market-data pages for AVOA, as either a common stock or an exchange-traded fund, were not available, and a full-text search of U.S. Securities and Exchange Commission filings returned no operating …
Tenaya Therapeutics is a South San Francisco-based clinical-stage biotechnology company developing therapies for genetic and other forms of heart disease. Its lead gene-therapy programs are TN-201, aimed at MYBPC3-associated hypertrophic cardiomyopathy, and TN-401, targeting PKP2-associated arrhythmogenic right ventricular cardiomyopathy. On August 5, 2026, Tenaya …
Stryker (SEC CIK 310764) is a diversifiedMedTechgiant organized around two broad segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. Its portfolio spans surgical instruments, hospital equipment, neurovascular devices, trauma and joint-replacement implants, and - most visibly - the Mako robotic-arm platform used in orthopedic …
Nutriband (SEC CIK 1676047) is a pharmaceutical company focused on transdermal and topical products. Its centerpiece is the AVERSA abuse-deterrent transdermal technology, designed to be incorporated into patches - most prominently an abuse-deterrent fentanyl patch - to help deter misuse, diversion and accidental exposure. …
Headquartered in Las Vegas, Nevada, PharmaCyte Biotech built its early identity around "Cell-in-a-Box," a live-cell encapsulation technology once positioned for pancreatic cancer and other indications. In recent years the company has shifted decisively away from clinical spending and toward what it frames as tactical …
Emergent BioSolutions is a life-sciences company built around public-health preparedness. Its portfolio spans the CYFENDUS and BioThrax anthrax vaccines, the ACAM2000 smallpox and mpox vaccine, botulism antitoxin (BAT), and the over-the-counter NARCAN naloxone nasal spray used to reverse opioid overdoses. Much of its revenue …
Cardio Diagnostics is a precision-cardiovascular-medicine company that combines epigenetics, genetics and artificial intelligence, using DNA-methylation biomarkers andMachine Learningto assess and detect coronary heart disease. Its core products are the Epi+Gen CHD risk-assessment test and the PrecisionCHD detection test, alongside its HeartRisk and CardioInnovate360 offerings. …
Bolt Biotherapeutics develops cancer immunotherapies built on its Boltbody Immune-Stimulating Antibody Conjugate, or ISAC, platform, which pairs tumor-targeting antibodies with immune-activating payloads. Its lead candidate, BDC-4182, is a next-generation ISAC targeting claudin 18.2 for gastric and gastroesophageal junction cancers, and it is advancing through …
Decoy Therapeutics develops AI-designed peptide-conjugate therapeutics through its IMP3ACT platform, which it uses to create what it calls Designable Multi-Antivirals, or D-MAVs, single drugs engineered to work across multiple viruses rather than one at a time. The company says it targets more than 250 …